On March 31, 2020, Nexien BioPharma, Inc. announced that Alex Wasyl resigned as the chief executive officer and a director of the company due to personal reasons. Richard Greenberg, one of the founders of the company and an existing director, will serve as interim chief executive officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0179 USD | +1.33% | -21.15% | -30.89% |
1st Jan change | Capi. | |
---|---|---|
-30.89% | 1.21M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+13.62% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- NXEN Stock
- News Nexien BioPharma, Inc.
- Nexien BioPharma, Inc. Announces Management Changes